However, this study confirmed that ALDH1 positive synovial sarcomas had a significantly poorer prognosis compared to ALDH1 negative synovial sarcomas (160), providing an alternative prognosis marker to CD44. The gene discussed is ALDH1A1; the disease is synovial sarcoma.